Combing stereotactic body radiotherapy with checkpoint inhibitors after oligoprogression in advanced non-small cell lung cancer

BACKGROUND: Immunotherapy has brought substantial benefit for patients with advanced non-small cell lung cancer (NSCLC); however, resistance may occur, of which oligoprogression is most common. There are no standard strategies to overcome acquired resistance, thus exploring potential effective appro...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhen, Wei, Lingyun, Li, Jing, Zhou, Han, Li, Si, Chen, Dongsheng, Yu, Yangyang, Zhao, Lele, Zhu, Xixu, Song, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743519/
https://www.ncbi.nlm.nih.gov/pubmed/35070747
http://dx.doi.org/10.21037/tlcr-21-682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743519/
https://www.ncbi.nlm.nih.gov/pubmed/35070747
http://dx.doi.org/10.21037/tlcr-21-682

Ejemplares similares